“Congress must act before the end of 2024 to provide clinicians with the financial stability needed to ensure beneficiaries continue to have access to high-quality care,” the groups wrote. 

The American Telemedicine Association, an industry lobby representing companies and providers, fears a crackdown from the DEA would harm patients who rely on virtual care to get vital treatments. 

The publicly traded, Los Angeles-based company is convening an all-day event in Maryland, where it operates nearly 60 outpatient imaging centers. 

CMS first started allowing this perk in response to the COVID-19 pandemic, with providers able to oversee exams using real-time audio and visual technology. 

The administration has now authorized a total of 69 medical products that incorporate AR/VR since 2015, including 28 in radiology. 

Baltimore sued eight companies that it claimed profited off the city’s opioid epidemic. To date, the government has received $402.5 million in settlements. 

U.S. Rep. Rosa DeLauro, D-Conn., convened the hearing a day before new FDA breast density notification requirements were set to go into effect on Sept. 10. 

NRC estimates that 29 of these “medical events” occurred between 2021 and 2023, with “many” involving new therapeutic radiopharma procedures.